On page 2000, the conflict-of-interest disclosures should include a statement that author Carolyn Grove served on advisory boards for AbbVie, Astellas, and Otsuka.
In the visual abstract, in the first bullet point under “Outcomes,” “MMR at 12 months was 79%, and MR4.5 at 24 months was 53%” should read “MMR by 12 months was 79%, and MR4.5 by 24 months was 53%.” In the graph, in the text label for the MR4.5 curve, the MR4.5 by 24 months should be 52.9%, not 64.9%. The corrected visual abstract is shown below.
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal